Background-The hepatitis G virus (HGV), a recently identified member o
f the Flaviviridae family, can cause chronic infection in man but the
role of this agent in chronic liver disease is poorly understood. Aims
-To evaluate the prevalence and meaning of HGV infection in a large se
ries of patients with chronic liver disease. Subjects-Two hundred volu
nteer blood donors, 179 patients with chronic hepatitis C, 111 with ch
ronic hepatitis B, 104 with alcoholic liver disease, 136 with hepatoce
llular carcinoma, and 24 with cryptogenic chronic liver disease were s
tudied. Methods-HGV RNA was investigated in serum samples by reverse t
ranscription and polymerase chain reaction amplification of the 5' non
-coding region of HCV and hybridisation to a specific probe. The main
features of HGV RNA seropositive and seronegative patients were compar
ed. Results-The prevalence of HGV infection was 3% in blood donors, 7%
in chronic hepatitis C, 8% in chronic hepatitis B, 2% in alcoholic li
ver disease, 4% in hepatocellular carcinoma, and 8% in cryptogenic chr
onic liver disease. HGV infected patients tended to be younger than no
ninfected patients but no differences concerning sex, possible source
of infection, clinical manifestations, biochemical and virological par
ameters, or severity of liver lesions were found. Conclusions-The prev
alence of HGV infection in chronic liver disease seems to be relativel
y low in our area. Infection with HGV does not seem to play a signific
ant pathogenic role in patients with chronic liver disease related to
chronic HBV or HCV infection or to increased alcohol consumption, or i
n those with cryptogenic chronic liver disease.